- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Onconic Therapeutics Inc (476060)
Onconic Therapeutics Inc stock price live, this page displays KQ 476060 stock exchange data. View the 476060 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Onconic Therapeutics Inc real time stock price chart below.
What Is the Onconic Therapeutics Inc Stock Price Today?
The Onconic Therapeutics Inc stock price today is 14,250.
What Is the Stock Symbol for Onconic Therapeutics Inc?
The stock symbol for Onconic Therapeutics Inc is "476060."
What Stock Exchange Does Onconic Therapeutics Inc Trade On?
Onconic Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Onconic Therapeutics Inc a Good Stock to Buy?
Determining whether Onconic Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 476060 quote. (ISIN: KR7476060009)
What Is the Onconic Therapeutics Inc Stock Price Today?
The Onconic Therapeutics Inc stock price today is 14,250.
What Is the Stock Symbol for Onconic Therapeutics Inc?
The stock symbol for Onconic Therapeutics Inc is "476060."
What Stock Exchange Does Onconic Therapeutics Inc Trade On?
Onconic Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Onconic Therapeutics Inc a Good Stock to Buy?
Determining whether Onconic Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 476060 quote. (ISIN: KR7476060009)
14,250
-560(-3.78%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,110
15,000
52 wk Range
5,663
65,200
476060 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,11015,000
52 wk Range
5,66365,200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
476060 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
12,500
Downside
-12.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12,500
(-12.28% Downside)
Earnings
Latest Release
Aug 12, 2026
EPS / Forecast
-- / --
Revenue / Forecast
21.2B / --
Compare 476060 to Peers and Sector
Metrics to compare | 476060 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship476060PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.2x | −9.4x | −0.3x | |
PEG Ratio | 0.05 | −0.30 | 0.00 | |
Price/Book | 8.2x | 1.9x | 2.6x | |
Price / LTM Sales | 9.7x | 9.6x | 3.1x | |
Upside (Analyst Target) | −12.3% | 0.0% | 49.0% | |
Fair Value Upside | Unlock | 20.4% | 6.3% | Unlock |
Onconic Therapeutics Inc. engages in the research and development of anti-cancer therapy in South Korea. It develops Zastaprazan (OCN-101), a potassium-competitive acid blocker, which is in phase 3 for the treatment of gastric acid related disease; and OCN-201 (JPI-547), an anticancer drug; JP-1366, a treatment for peptic ulcer; and drugs for DDR and immuno-oncology fields. JP-1366, a poly ADP-ribose polymerase inhibitor, which is in phase 1 for the treatment of pancreatic cancer. The company was founded in 2020 and is based in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Onconic Therapeutics (476060) Stock Price Today?
The Onconic Therapeutics stock price today is 14,250 KRW.
What Stock Exchange Does Onconic Therapeutics Trade On?
Onconic Therapeutics is listed and trades on the KOSDAQ.
What Is the Stock Symbol for Onconic Therapeutics?
The stock symbol for Onconic Therapeutics is "476060."
What Is the Onconic Therapeutics Market Cap?
As of today, Onconic Therapeutics market cap is 672.49B KRW.
What Is Onconic Therapeutics's Earnings Per Share (TTM)?
The Onconic Therapeutics EPS (TTM) is 441.
When Is the Next Onconic Therapeutics Earnings Date?
Onconic Therapeutics will release its next earnings report on Nov 17, 2026.
From a Technical Analysis Perspective, Is 476060 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Onconic Therapeutics Stock Split?
Onconic Therapeutics has split 1 times.
What is the current trading status of Onconic Therapeutics (476060)?
As of Aug 18, 2026, Onconic Therapeutics (476060) is trading at a price of 14,250 KRW, with a previous close of 14,810 KRW. The stock has fluctuated within a day range of 14,110 KRW to 15,000 KRW, while its 52-week range spans from 5,663 KRW to 65,200 KRW.
What Is Onconic Therapeutics (476060) Price Target According to Analysts?
The average 12-month price target for Onconic Therapeutics is 12,500 KRW, with a high estimate of 12500 KRW and a low estimate of 12500 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -12.28% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.